Please provide your email address to receive an email when new articles are posted on . The introduction of long-acting injectable cabotegravir PrEP in sub-Saharan Africa could result in fewer future ...

HIV (human immunodeficiency virus) remains a significant global health challenge, affecting millions of people worldwide. While advancements in medical science have led to better management of the ...

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics. 259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...

Add Yahoo as a preferred source to see more of our stories on Google. Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option for ...

Gilead Sciences is coming off of a milestone year that saw the start of the much-anticipated launch of the world’s first twice-yearly injectable HIV pre-exposure prophylaxis (PrEP) medicine Ye | ...

This week, October 25 - 29, is PrEP Awareness Week, so we wanted to give you the latest information about this highly effective (up to 99 percent when taken as prescribed!) method of preventing HIV ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

ViiV expects injectables to steal significant market share from oral treatments, such as Gilead’s Biktarvy, which currently dominate the HIV field. In the prevention arena, the company is awaiting an ...

Credit: Getty Images Since the introduction of HIV PrEP in the MSM population, the incidence of other STIs has increased likely because of changes in sexual behaviors and condom use. • PrEP decreased ...